Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Topotecan and Cisplatin in Recurrent/Persistent Cervical Cancer
NCT00548418Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2007
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in Cervical Cancer (CC), sponsored by Washington University School of Medicine. Started Feb 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00548418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548418.